Building a Decentralized & Accelerated mRNA Vaccine Production System (DeCAFx) for Pandemic Preparedness

Time: 10:00 am
day: Day Two

Details:

• DeCAFx, led by IVI, is a decentralized, modular mRNA manufacturing platform for rapid, regional pandemic response
• Collaborating globally on mRNA R&D, including vaccines for Lassa and Rift Valley fevers, saRNA, and novel delivery methods
• Aligning with CEPI’s 100 Days Mission, DeCAFx aims to enable vaccine rollout within weeks of pathogen detection

Speakers:

Sang Hwan Seo Dr. Sang Hwan Seo is the Director at the International Vaccine Institute (IVI) and Adjunct Professor at Yonsei University College of Medicine. Since joining the Read more